Differential In Vitro Effects of SGLT2 Inhibitors on Mitochondrial Oxidative Phosphorylation, Glucose Uptake and Cell Metabolism

(1) The cardio-reno-metabolic benefits of the SGLT2 inhibitors canagliflozin (cana), dapagliflozin (dapa), ertugliflozin (ertu), and empagliflozin (empa) have been demonstrated, but it remains unclear whether they exert different off-target effects influencing clinical profiles. (2) We aimed to inve...

Descripción completa

Detalles Bibliográficos
Autores principales: Zügner, Elmar, Yang, Hsiu-Chiung, Kotzbeck, Petra, Boulgaropoulos, Beate, Sourij, Harald, Hagvall, Sepideh, Elmore, Charles S., Esterline, Russell, Moosmang, Sven, Oscarsson, Jan, Pieber, Thomas R., Peng, Xiao-Rong, Magnes, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319636/
https://www.ncbi.nlm.nih.gov/pubmed/35887308
http://dx.doi.org/10.3390/ijms23147966

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319636/
https://www.ncbi.nlm.nih.gov/pubmed/35887308
http://dx.doi.org/10.3390/ijms23147966

Ejemplares similares